Dan Sharp
Inflammatory Bowel Disease advocate
Twitter Instagram Facebook
 
Skip to content
  • Articles
  • Resources
    • Articles
    • Pharmaceutical Financial Assistance
    • Free Restroom Access Cards
    • Camps for Kids with IBD
  • About Me
  • Contact Me
  • Events
    • How to Join a Twitter Chat
    • University of Michigan’s Virtual Patient-2-Patient Education Project (Oct 3, 2020)
    • #GutOverHere – patient meetups
    • Camps for Kids with IBD

Category: Diet and Nutrition

No comments

What is The Difference Between Nutrition & Diet?

  By Dan Sharp August 9, 2016 June 3, 2019 Articles, Diet and Nutrition, Education, F.A.Q.
What is the Difference Between Nutrition & Diet?   Nutrition refers to “the act or process of nourishing or being nourished”. To be nourished, to have good nutrition, means getting appropriate amounts of…
No comments

The Alkaline Diet: A Brief Overview

  By Dan Sharp October 2, 2015 September 28, 2018 Articles, Diet and Nutrition, Education, Medical
The Alkaline Diet   Many Inflammatory Bowel Disease (IBD) patients find that dietary choices have an influence on their symptoms. Unfortunately, food that is easy to tolerate for one…
  • Content Categories

  • Recent Posts

    • U of Michigan’s Patient-2-Patient Education Project 2021
    • That’s Not “Chemo” (The Mislabeling of IBD Treatments)
    • The University of Michigan’s Patient-2-Patient Education Project
    • Logical Fallacies in Online Patient Groups
    • How to Join a Twitter Chat
  • Twitter

    Dan SharpFollow

    Patient advocate | Medical Laboratory Scientist🔬 (ASCP) | #DisruptiveInnovator | Interests include cats, stats, & science-based medicine | #IBD

    Dan Sharp
    Retweet on TwitterDan Sharp Retweeted
    ibddoctorPeter Higgins@ibddoctor·
    12 May

    The delta of 33% for clinical remission by CDAI is pretty impressive, especially with a lot of bio-experienced patients. Larger than IFX in the bionaive era in ACCENT. https://twitter.com/mchiorean4/status/1524768083285405697

    Michael Chiorean@mchiorean4

    Upadacitinib (selective JAK1-inhibitor) achieved all clinical & endoscopic endpoints for maintenance in #CrohnsDisease in the phase 3 program. Number needed to treat of 3 for clinical and 4 for endoscopic endpoints. Great news for our #IBD patients https://news.abbvie.com/news/press-releases/upadacitinib-rinvoq-achieved-clinical-remission-and-endoscopic-response-at-one-year-in-phase-3-maintenance-study-in-patients-with-crohns-disease.htm?view_id=2421

    Reply on Twitter 1524770614963322880Retweet on Twitter 152477061496332288013Like on Twitter 152477061496332288052Twitter 1524770614963322880
    Retweet on TwitterDan Sharp Retweeted
    MikeKattahMDKattahLab@MikeKattahMD·
    23 Apr

    Breaking therapeutic ceiling in UC With Upa @ibddoctor @TimSimpsonMD @UCDavisGI @rkhsusa @ucsfibd

    Reply on Twitter 1517893773316952064Retweet on Twitter 15178937733169520647Like on Twitter 151789377331695206435Twitter 1517893773316952064
Copyright Dan Sharp 2018. Disclaimer
Powered by Parabola & WordPress.
Twitter Instagram Facebook